Company / Shares Outstanding
Viking Therapeutics, Inc. Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
111.6M
FY2025
5-year range
73.2M / 111.6M
FY2021-FY2025
Trend
+11.4%
vs FY2024
Sector context
#89 of 212
Health Care
What the data says
At 111573519.00, Viking Therapeutics, Inc.'s shares outstanding ranks #124 of 212 in the Health Care sector. Shares Outstanding has increased for 9 consecutive years, from 9683741.00 in FY2016 to 111573519.00 in FY2025.
Based on SEC 10-K filings.
111573519.00 in FY2025 with a 5-year CAGR of +9.0%.
Increased from 78257258.00 to 111573519.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +12.6%
- 5-Year CAGR
- +9.0%
- 10-Year CAGR
- -
Sector benchmark
#124 of 212 in Health CareTop 58% of 212This company 111.6M Sector average 306.7M
▼
-63.6% below sector average
Key checks
Key Insights
- Viking Therapeutics, Inc.'s shares outstanding has grown for 9 consecutive years.
- In FY2025, shares outstanding increased 11.4% year-over-year.
- Ranks #89 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 111.6M | +11.4% |
| FY2024 | 100.1M | +27.9% |
| FY2023 | 78.3M | +0.0% |
| FY2022 | 78.2M | +6.9% |
| FY2021 | 73.2M | +1.1% |
| FY2020 | 72.4M | +0.9% |
| FY2019 | 71.7M | +100.3% |
| FY2018 | 35.8M | +72.0% |
| FY2017 | 20.8M | +115.0% |
| FY2016 | 9.7M | +61.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026